Controversies in the treatment of prostate cancer with maximal androgen deprivation.
Published
Book Section
The concept of maximal androgen deprivation (MAD) has become the accepted therapy for metastatic prostate cancer. MAD is also under investigation as neoadjuvant therapy prior to radical prostatectomy and radiation therapy. Innovative new approaches, such as intermittent androgen deprivation and new combination therapies, will emerge over the next decade.
Full Text
Duke Authors
Cited Authors
- McLeod, DG; Moul, JW
Published Date
- April 1995
Volume / Issue
- 4 /
Start / End Page
- 345 - 359
PubMed ID
- 7796290
Pubmed Central ID
- 7796290
Digital Object Identifier (DOI)
- 10.1016/s1055-3207(18)30459-9